BioSpace News Archive

Anixa Biosciences, Inc. announced its participation at two upcoming investor conferences in New York City.

Lock-up includes founders, early shareholders and other key stakeholders and represents approximately 47% of outstanding shares (common equivalents)

Prancer RTSM Selected for Innovation in Cohort Management for Highly Complex Trials

Atonarp, a hi-tech molecular diagnostics company, announced that it has raised $33 million in an oversubscribed Series C funding round.

BELLUS Health Inc. announced the appointment of Dr. Catherine Bonuccelli, MD to the role of Chief Medical Officer.

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate appointment of Priya Chaturvedi, Ph.D., as Vice President, Global Clinical Quality Assurance.

CBD of Denver, Inc. (OTC CBDD) is pleased to announce the relaunch of our E-Commerce Web Site www.blackpearlcbd.com.

Confirm BioSciences, a leading developer of high-quality diagnostic testing and health and wellness solutions, today announced Albert “Albie” Berger has been selected as Confirm BioSciences’ new chief executive officer. Berger succeeds founder Zeynep Ilgaz, who will assume the roles of chairwoman of the board of directors and chief advisor.

Iora Primary Care today announced the opening of five practices in North Carolina providing high quality primary care to older adults on Medicare

Physician’s Seal, LLC® (PS) today announced favorable results from its REMfresh® Safety Update at 24 Months (REMSU24) for REMfresh® continuous release and absorption melatonin (CRA-melatonin™), a real-world surveillance study reporting on the safety and tolerability profile of REMfresh